Y06137
Y06137 is a potent and selective BET inhibitor for treatment of castration-resistant prostate cancer (CRPC) . Y06137 binds to the BRD4 (1) bromodomain with a Kd of 81 nM[1].
Product Specifications
CAS Number
2226534-49-0
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Y06137.html
Purity
99.90
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
CC1=NOC(C1=C2)=CC=C2C3=NC(C=C4)=C(N3CC5CCCCC5)C=C4N6CCOC[C@@H]6C
Molecular Formula
C27H32N4O2
Molecular Weight
444.57
References & Citations
[1]Zhang M, et al. Structure-Based Discovery and Optimization of Benzo[ d]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC) . J Med Chem. 2018 Apr 12;61 (7) :3037-3058.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD4
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY400476 100 µg
Bak (BAK1) (NM_001188) Human Over-expression Lysate
Sign In for Pricing
View Details 
![CCN2 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI2G3]](https://cdn.genprice.uk/products/937/68dd1b7d061270361ea1d318/imageurl/ta806801bm.webp)
TA806801BM 100 µL
CCN2 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI2G3]
Sign In for Pricing
View Details